Skip to main content
TipRanks
Go Ultimate75% OFF

vTv Therapeutics (5VT0) Financial Statements

1 Followers

vTv Therapeutics Financial Overview

vTv Therapeutics's market cap is currently $70.63M. The company's EPS TTM is $0.30; its P/E ratio is 656.33; vTv Therapeutics is estimated to report earnings on March 17, 2027, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 1.02M$ 0.00$ 2.02M$ 4.00M
Gross Profit$ 0.00$ 1.02M$ 0.00$ 2.02M$ 4.00M
Operating Income$ -32.81M$ -24.18M$ -25.50M$ -22.54M$ -21.66M
EBITDA$ -31.06M$ -22.52M$ -25.86M$ -24.77M$ -17.52M
Net Income$ -26.97M$ -18.46M$ -20.25M$ -19.16M$ -12.99M
Balance Sheet
Cash & Short-Term Investments$ 88.93M$ 36.75M$ 9.45M$ 12.13M$ 13.41M
Total Assets$ 89.90M$ 38.27M$ 11.02M$ 33.24M$ 25.47M
Total Debt$ 0.00$ 169.00K$ 529.00K$ 716.00K$ 932.00K
Net Debt$ -88.93M$ -36.58M$ -8.92M$ -11.41M$ -12.48M
Total Liabilities$ 25.46M$ 23.96M$ 29.57M$ 27.40M$ 10.25M
Stockholders' Equity$ 64.44M$ 12.20M$ -24.68M$ -10.74M$ -9.74M
Cash Flow
Free Cash Flow$ -25.25M$ -25.31M$ -19.08M$ -15.27M$ -19.31M
Operating Cash Flow$ -25.25M$ -25.31M$ -19.08M$ -15.25M$ -19.31M
Investing Cash Flow$ 0.00$ 0.00$ 4.40M$ -21.00K$ 0.00
Financing Cash Flow$ 77.44M$ 52.61M$ 12.00M$ 13.98M$ 26.98M

Currency in USD

vTv Therapeutics Earnings and Revenue History

-30M-15M015M-6000 %-4000 %-2000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

vTv Therapeutics Liabilities to Assets

080M160M240M0 %400 %800 %1200 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

vTv Therapeutics Cash Flow

-75M-50M-25M025M50M75M100M201720182019202020212022202320242025OperatingInvestingFinancing

vTv Therapeutics Forecast EPS vs Actual EPS

-2-1012Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss